Fusions to the cholera toxin B subunit: Influence on pentamerization and GM1 binding

Journal of Immunological Methods

Volumn 210, Issue 2, 1997, Pages 125-135

  Liljeqvist, Sissela ^a   Ståhl, Stefan ^a   Andréoni, Christine ^b   Binz, Hans ^b   Uhlén, Mathias ^a   Murby, Maria ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Cholera toxin B subunit; Fusion protein; GM1 binding; Pentamerization; Streptococcal protein G

Indexed keywords

CHOLERA TOXIN B SUBUNIT; GANGLIOSIDE GM1; HYBRID PROTEIN;

ARTICLE; MOLECULAR INTERACTION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN PURIFICATION; VACCINE PRODUCTION;

ESCHERICHIA COLI;

EID: 0345055329     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00170-1     Document Type: Article

References (56)

1. Bäckström M., Lebens M., Schrödel F., Holmgren J. Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit. Gene. 149:1994;211.
2. Bäckström M., Holmgren J., Schödel F., Lebens M. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli. Gene. 165:1995;163.
3. Bäckström M., Shahabi V., Johansson S., Teneberg S., Kjellberg A., Miller-Podraza H., Holmgren J., Lebens M. Strucural basis for differential receptor-binding of cholera and Escherichia coli heat-labile toxins: Influence of heterologous amino acid substitutions in the cholera B-subunit. Mol. Microbiol. 24:1997;489.
4. Chen K.-S., Strober W. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: Disproportionate cholera toxin enhancement of the IgA B cell response. Eur. J. Immunol. 20:1990;433.
5. Cheng-hua S., Cheng C., Jing-sheng Z., Jiezhi L., Qing-jun M. Gene fusion of cholera toxin B subunit and HBV PreS2 epitope and the antigenicity of fusion protein. Vaccine. 13:1995;933.
6. Clements J.D. Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins. Infect. Immun. 58:1990;1159.
7. Czerkinsky C., Russell M.W., Lycke N., Lindblad M., Holmgren J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57:1989;1072.
8. Delmas A., Partidos C.D. The binding of chimeric peptides to GM1 ganglioside enables induction of antibody responses after intranasal immunization. Vaccine. 14:1996;1077.
9. Dertzbaugh M.T., Elson C.O. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect. Immun. 61:1993;48.
10. Dertzbaugh M.T., Elson C.O. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition. Infect. Immun. 61:1993;384.
11. Dertzbaugh M.T., Peterson D.L., Macrina F.L. Cholera toxin B-subunit gene fusion: Structural and functional analysis of the chimeric protein. Infect. Immun. 58:1990;70.
12. González R.A., Sánchez J., Holmgren J., López S., Arias C.F. Immunological characterization of a rotavirus-neutralizing epitope fused to the cholera toxin B subunit. Gene. 133:1993;227.
13. Hajishengallis G., Hollingshead S.K., Koga T., Russel M.W. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunol. 154:1995;4322.
14. Hammarberg B., Nygren P.-Å., Holmgren E., Elmblad A., Tally M., Hellman U., Moks T., Uhlén M. Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II. Proc. Natl. Acad. Sci. USA. 86:1989;4367.
15. Hardy S.J.S., Holmgren J., Johansson S., Sanchez J., Hirst T.R. Coordinated assembly of multisubunit proteins: Oligomerization of bacterial enterotoxins in vivo and in vitro. Proc. Natl. Acad. Sci. USA. 85:1988;7109.
16. Hirabayashi Y., Kurata H., Funato H., Nagamine T., Aizawa C., Tamura S.-I., Shimada K., Kurata T. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine. 8:1990;243.
17. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 11:1993;1179.
18. Holmgren J., Czerkinsky C., Lycke N., Svennerholm A.-M. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am. J. Trop. Med. Hyg. 50:1994;42.
19. Hultman T., Ståhl S., Hornes E., Uhlén M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucl. Acids Res. 17:1989;4937.
20. Hultman T., Ståhl S., Moks T., Uhlén M. Approaches to solid phase DNA sequencing. Nucl. Nucl. 7:1988;629.
21. Hultman T., Bergh S., Moks T., Uhlén M. Bidirectional solid-phase sequencing of in vitro-amplified plasmid DNA. BioTechniques. 10:1991;84.
22. Jagusztyn-Krynicka E.K., Clark-Curtiss J.E., Curtiss III R. Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: Importance of the linker for antigenicity and biological activities of the hybrid proteins. Infect. Immun. 61:1993;1004.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
24. Lehner T., Tao L., Panagiotidi C., Klavinskis L.S., Brookes R., Hussain L., Meyers N., Adams S.E., Gearing A.J.H., Bergmeier L.A. Mucosal model of genital immunization in male Rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol. 68:1994;1624.
25. Liljeqvist S., Samuelson P., Hansson M., Nguyen T.N., Binz H., Ståhl S. Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus. Appl. Environ. Microbiol. 63:1997;2481.
26. Lipscombe M., Charles I.G., Roberts M., Dougan G., Tite J., Fairweather N.F. Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen. Mol. Microbiol. 5:1991;1385.
27. Löwenadler B., Jansson B., Paleus S., Holmgren E., Nilsson B., Moks T., Palm G., Josephson S., Philipson L., Uhlén M. A gene fusion system for generating antibodies against short peptides. Gene. 58:1987;87.
28. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine. 10:1992;75.
29. McKenzie S.J., Halsey J.F. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 133:1984;1818.
30. Mekalanos J.J., Swartz D.J., Pearson G.D.N., Harford N., Groyne F., de Wilde M. Cholera toxin genes: Nucleotide sequence, deletion analysis and vaccine development. Nature. 306:1983;551.
31. Nashar T.O., Amin T., Marcello A., Hirst T.R. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine. 11:1993;235.
32. Nguyen T.N., Gourdon M.-H., Hansson M., Robert A., Samuelson P., Libon C., Andréoni C., Nygren P.-Å., Binz H., Uhlén M., Ståhl S. Hydrophobicity engineering to facilitate surface display of heterologous gene products on Staphylococcus xylosus. J. Biotechnol. 42:1995;207.
33. Nilsson B., Moks T., Jansson B., Abrahmsén L., Elmblad A., Holmgren E., Henrichson C., Jones T.A., Uhlén M. A synthetic IgG-binding domain based on staphylococcal protein A. Prot. Eng. 1:1987;107.
34. Nossal N.G., Heppel L.A. The release of enzymes by osmotic chock from Escherichia coli in exponential phase. J. Biol. Chem. 241:1966;3055.
35. Nygren P.-Å., Eliasson M., Palmcrantz E., Abrahmsén L., Uhlén M. Analysis and use of the serum albumin binding domains of streptococcal protein G. J. Mol. Recognit. 1:1988;69.
36. Nygren P.-Å., Ståhl S., Uhlén M. Engineering proteins to facilitate bioprocessing. Trends Biotechnol. 12:1994;18.
37. Öberg, U., Rundström, G., Grönlund, H., Uhlén, M., Nygren, P.-Å., 1993. Intracellular production and renaturation from inclusion bodies of a scFv fragment fused to a serum albumin binding affinity tail. In: Alberghina, L., Frontali, P., Sensi, P. (Eds), 6th Eur. Congr. Biotechnol. Elsevier Science B.V., Amsterdam. p. 179.
38. Oien N.J., Brideau R.J., Walsh E.E., Wathen M.W. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine. 12:1994;731.
39. Power U.F., Plotnicky-Gilquin H., Huss T., Nguyen T.N., Robert A., Trudel M., Ståhl S., Uhlén M., Binz H. Induction of protective immunity in rodents by vaccination with a prokaryotically-expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. Virology. 230:1997;155.
40. Rüther U. pUR 250 allows rapid chemical sequencing of both DNA strands of its insert. Nucl. Acids Res. 10:1982;5765.
41. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor. NY.
42. Sanchez J., Holmgren J. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc. Natl. Acad. Sci. USA. 86:1989;481.
43. Sanchez J., Svennerholm A.-M., Holmgren J. Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit. FEBS Lett. 241:1988;110.
44. Sanchez J., Johansson S., Löwenadler B., Svennerholm A.M., Holmgren J. Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination. Res. Microbiol. 141:1990;971.
45. Sandkvist M., Hirst T.R., Bagdasarian M. Alterations at the carboxyl terminus change assembly and secretion properties of the B subunit of Escherichia coli heat-labile enterotoxin. J. Bacteriol. 169:1987;4570.
46. Schödel F., Enders G., Jung M.-C., Will H. Recognition of a hepatitis B virus nucleocapsid T-cell epitope expressed as a fusion protein with the subunit B of Escherichia coli heat-labile enterotoxin in attenuated salmonellae. Vaccine. 8:1990;569.
47. Sjölander A., Nygren P.-Å., Ståhl S., Berzins K., Uhlén M., Perlmann P., Andersson R. The serum albumin binding region of streptococcal protein G: A bacterial fusion partner with carrier-related properties. J. Immunol. Methods. 201:1997;515.
48. Staats H.F., Jackson R., Marinaro M., Takahashi I., Kiyono H., McGhee J.R. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immunol. 6:1994;572.
49. Ståhl S., Sjölander A., Nygren P.-Å., Berzins K., Perlmann P., Uhlen M. A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. J. Immunol. Methods. 124:1989;43.
50. Ståhl S., Sjölander A., Hansson M., Nygren P.-Å., Uhlén M. A general strategy for polymerization, assembly and expression of epitope-carrying peptides applied to the Plasmodium falciparum antigen Pf155/RESA. Gene. 89:1990;187.
51. Strauch K.L., Beckwith J. An Eschericia coli mutation preventing degradation of abnormal periplasmic proteins. Proc. Natl. Acad. Sci. USA. 85:1988;1576.
52. Strauch K.L., Beckwith J. Characterization of degP, a gene required for proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature. J. Bacteriol. 171:1989;2689.
53. Svennerholm A.-M., Wikström M., Lindblad M., Holmgren J. Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay. J. Clin. Microbiol. 24:1986;585.
54. Tamura S.-I., Samegai Y., Kurata H., Nagamine T., Aizawa C., Kurata T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine. 6:1988;409.
55. Zhang R.-G., Westbrook M.L., Westbrook E.M., Scott D.L., Otwinowski Z., Maulik P.R., Reed R.A., Shipley G.G. The 2.4 Å crystal structure of cholera toxin B subunit pentamer: Choleragenoid. J. Mol. Biol. 251:1995;550.
56. Zhang T., Li E., Stanley S.L. Jr. Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Infect. Immun. 63:1995;1349.